Travere Therapeutics TVTX

$ 18.48 -0.43%

Quarterly report 2024-Q3
added 10-31-2024

Travere Therapeutics Accounts Payables 2011-2024 | TVTX

Annual Accounts Payables Travere Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
41.7 M	17.3 M	15.1 M	12.1 M	26.6 M	6.95 M	18.9 M	7.52 M	7.64 M	7.12 M	3.55 M	1.02 M	340 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
41.7 M	340 K	12.8 M

Quarterly Accounts Payables Travere Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
23.2 M	25.8 M	16.7 M	41.7 M	24.7 M	19.9 M	16.7 M	17.3 M	14 M	-	18.4 M	15.1 M	5.83 M	8.34 M	15 M	12.1 M	12.1 M	12.1 M	12.1 M	26.6 M	26.6 M	26.6 M	26.6 M	6.95 M	6.95 M	6.95 M	6.95 M	18.9 M	18.9 M	18.9 M	18.9 M	7.52 M	7.52 M	7.52 M	7.52 M	7.64 M	7.64 M	7.64 M	7.64 M	7.12 M	7.12 M	7.12 M	7.12 M	3.55 M	3.55 M	3.55 M	3.55 M	1.02 M	1.02 M	1.02 M	1.02 M	340 K	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
41.7 M	340 K	12.3 M